logo
搜索
菜单

concentrat的搜索结果

当前1/19页
排序: 最近更新
Improving IV Insulin Administration in a Community Hospital 10.3791/3705-v
Improving IV Insulin Administration in a Community Hospital
25.2: Glucose Homeostasis: Pancreatic Islets and Insulin Secretion 01:27 min
25.2: Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
16.12: Oral Drug Delivery Systems: Continuous-Release Systems 01:26 min
16.12: Oral Drug Delivery Systems: Continuous-Release Systems
16.5: Modified-Release Drug Delivery Systems: Drug Release Characteristics 01:22 min
16.5: Modified-Release Drug Delivery Systems: Drug Release Characteristics
16.4: Modified-Release Drug Delivery Systems: Bioavailability 01:30 min
16.4: Modified-Release Drug Delivery Systems: Bioavailability
16.2: Modified-Release Drug Delivery Systems: Overview 01:19 min
16.2: Modified-Release Drug Delivery Systems: Overview
15.15: Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model 01:14 min
15.15: Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
15.14: Pharmacodynamic Models: Direct Effect Model and Indirect Response Model 01:29 min
15.14: Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
15.12: Pharmacodynamic Models: Logarithmic Concentration–Effect Model 01:15 min
15.12: Pharmacodynamic Models: Logarithmic Concentration–Effect Model
15.11: Pharmacodynamic Models: Linear Concentration–Effect Model 01:15 min
15.11: Pharmacodynamic Models: Linear Concentration–Effect Model
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components 01:14 min
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems 01:24 min
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems
15.4: Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship 01:23 min
15.4: Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
15.3: Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship 01:14 min
15.3: Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect 01:28 min
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant 01:25 min
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
13.16: Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug 01:14 min
13.16: Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
13.5: Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution 01:00 min
13.5: Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
12.13: IV Infusion to Oral Dosing: Conversion Methods 01:28 min
12.13: IV Infusion to Oral Dosing: Conversion Methods
12.13: IV Infusion to Oral Dosing: Conversion Methods 01:28 min
12.13: IV Infusion to Oral Dosing: Conversion Methods
返回顶部